104 related articles for article (PubMed ID: 25885786)
1. Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion.
Lee JY; Youm J; Kim JW; Cho JY; Kim MA; Kim TH; Suh DH; Lim MC; Park NH; Song YS
BMC Cancer; 2015 Mar; 15():167. PubMed ID: 25885786
[TBL] [Abstract][Full Text] [Related]
2. Preoperative MRI criteria for trials on less radical surgery in Stage IB1 cervical cancer.
Lee JY; Youm J; Kim TH; Cho JY; Kim MA; Suh DH; Lim MC; Kim JW; Park NH; Song YS
Gynecol Oncol; 2014 Jul; 134(1):47-51. PubMed ID: 24768849
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
Kim M; Suh DH; Kim K; Lee HJ; Kim YB; No JH
Int J Gynecol Cancer; 2017 Feb; 27(2):332-338. PubMed ID: 28114236
[TBL] [Abstract][Full Text] [Related]
4. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.
Yamazaki H; Todo Y; Okamoto K; Yamashiro K; Kato H
J Gynecol Oncol; 2015 Oct; 26(4):255-61. PubMed ID: 26197769
[TBL] [Abstract][Full Text] [Related]
6. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Jul; 126(1):82-6. PubMed ID: 22516661
[TBL] [Abstract][Full Text] [Related]
7. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Kato T; Takashima A; Kasamatsu T; Nakamura K; Mizusawa J; Nakanishi T; Takeshima N; Kamiura S; Onda T; Sumi T; Takano M; Nakai H; Saito T; Fujiwara K; Yokoyama M; Itamochi H; Takehara K; Yokota H; Mizunoe T; Takeda S; Sonoda K; Shiozawa T; Kawabata T; Honma S; Fukuda H; Yaegashi N; Yoshikawa H; Konishi I; Kamura T;
Gynecol Oncol; 2015 Apr; 137(1):34-9. PubMed ID: 25662625
[TBL] [Abstract][Full Text] [Related]
8. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
[TBL] [Abstract][Full Text] [Related]
10. Stage IB1 cervical cancer patients with an MRI-measured tumor size < or = 2 cm might be candidates for less-radical surgery.
Kodama J; Fukushima C; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
Eur J Gynaecol Oncol; 2013; 34(1):39-41. PubMed ID: 23589998
[TBL] [Abstract][Full Text] [Related]
11. How important is removal of the parametrium at surgery for carcinoma of the cervix?
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
Diaz JP; Sonoda Y; Leitao MM; Zivanovic O; Brown CL; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):255-60. PubMed ID: 18755500
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Parametrial Involvement in Early Stages Cervical Cancer With Preoperative Magnetic Resonance Imaging.
He F; Du J; Chen X; He L
Int J Gynecol Cancer; 2018 Nov; 28(9):1758-1765. PubMed ID: 30153214
[TBL] [Abstract][Full Text] [Related]
14. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy.
Stegeman M; Louwen M; van der Velden J; ten Kate FJ; den Bakker MA; Burger CW; Ansink AC
Gynecol Oncol; 2007 May; 105(2):475-80. PubMed ID: 17292460
[TBL] [Abstract][Full Text] [Related]
15. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of less radical surgery for superficially invasive carcinoma of the cervix.
Kim MK; Kim JW; Kim MA; Kim HS; Chung HH; Park NH; Park IA; Song YS; Kang SB
Gynecol Oncol; 2010 Nov; 119(2):187-91. PubMed ID: 20663542
[TBL] [Abstract][Full Text] [Related]
17. Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience.
Maneo A; Sideri M; Scambia G; Boveri S; Dell'anna T; Villa M; Parma G; Fagotti A; Fanfani F; Landoni F
Gynecol Oncol; 2011 Dec; 123(3):557-60. PubMed ID: 21907396
[TBL] [Abstract][Full Text] [Related]
18. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
19. An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer.
Lee JY; Youm J; Kim JW; Kim K; Kim HJ; Cho JY; Kim MA; Park NH; Song YS
Cancer Res Treat; 2016 Jan; 48(1):259-65. PubMed ID: 25797571
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenectomy alone is a feasible option in managing incidentally-detected early-stage cervical cancer after simple hysterectomy without intermediate-risk factors: An application of the concept of less radical surgery.
Jeon HW; Suh DH; Kim K; No JH; Kim YB
Anticancer Res; 2013 Nov; 33(11):5135-41. PubMed ID: 24222161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
